Proderme Overview
- Year Founded
-
2021
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Proderme General Information
Description
Developer of a transdermal drug delivery platform designed to provide needle-free medication administration. The company's platform utilises topical patches containing hundreds of biodegradable polymeric microneedles to release medications directly into the skin, enabling patients to administer complex medications including proteins and antibodies without the pain or risk of traditional needles.
Contact Information
Website
www.somosproderme.com.brCorporate Office
- Sao Paulo
- Brazil
Corporate Office
- Sao Paulo
- Brazil
Proderme Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 11-Aug-2026 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
Proderme Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Proderme FAQs
-
When was Proderme founded?
Proderme was founded in 2021.
-
Where is Proderme headquartered?
Proderme is headquartered in Sao Paulo, Brazil.
-
What industry is Proderme in?
Proderme’s primary industry is Drug Delivery.
-
Is Proderme a private or public company?
Proderme is a Private company.
-
What is Proderme’s current revenue?
The current revenue for Proderme is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
